MSCI Inc (MSCI) - Total Liabilities
Based on the latest financial reports, MSCI Inc (MSCI) has total liabilities worth $8.32 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
MSCI Inc - Total Liabilities Trend (2003–2025)
This chart illustrates how MSCI Inc's total liabilities have evolved over time, based on quarterly financial data. See MSCI net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
MSCI Inc Competitors by Total Liabilities
The table below lists competitors of MSCI Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Diageo plc
MX:DEON
|
Mexico | MX$36.58 Billion |
|
Banco Santander Brasil SA ADR
NYSE:BSBR
|
USA | $1.17 Trillion |
|
Bayerische Motoren Werke Aktiengesellschaft
XETRA:BMW
|
Germany | €166.41 Billion |
|
Ferguson Plc
NYSE:FERG
|
USA | $11.91 Billion |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
USA | $1.83 Billion |
|
Kia Corp
KO:000270
|
Korea | ₩37.79 Trillion |
|
STMicroelectronics N.V
F:SGMR
|
Germany | €6.96 Billion |
|
Victory Giant Technology Huizhou Co Ltd
SHE:300476
|
China | CN¥21.47 Billion |
Liability Composition Analysis (2003–2025)
This chart breaks down MSCI Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see MSCI stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.86 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -3.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.50 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how MSCI Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for MSCI Inc (2003–2025)
The table below shows the annual total liabilities of MSCI Inc from 2003 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $8.36 Billion | +30.88% |
| 2024-12-31 | $6.39 Billion | +2.04% |
| 2023-12-31 | $6.26 Billion | +4.20% |
| 2022-12-31 | $6.01 Billion | +5.91% |
| 2021-12-31 | $5.67 Billion | +22.15% |
| 2020-12-31 | $4.64 Billion | +8.43% |
| 2019-12-31 | $4.28 Billion | +20.45% |
| 2018-12-31 | $3.55 Billion | +23.65% |
| 2017-12-31 | $2.87 Billion | +3.97% |
| 2016-12-31 | $2.76 Billion | +23.13% |
| 2015-12-31 | $2.25 Billion | +53.66% |
| 2014-12-31 | $1.46 Billion | -6.21% |
| 2013-12-31 | $1.56 Billion | -2.27% |
| 2012-12-31 | $1.59 Billion | -10.81% |
| 2011-12-31 | $1.79 Billion | -8.00% |
| 2010-12-31 | $1.94 Billion | +180.30% |
| 2009-12-31 | $693.21 Million | -4.87% |
| 2008-12-31 | $728.67 Million | +3.41% |
| 2007-12-31 | $704.66 Million | +145.47% |
| 2006-12-31 | $287.06 Million | -1.12% |
| 2005-12-31 | $290.30 Million | +235.70% |
| 2003-12-31 | $86.48 Million | -- |
About MSCI Inc
MSCI Inc., together with its subsidiaries, provides research-based data, analytics, and indexes, supported by advanced technology worldwide. The Index segment provides indexes for use in various areas of the investment process, including indexed financial products, such as ETFs, mutual funds, annuities, futures, options, structured products, and over-the-counter derivatives; performance benchmark… Read more